Literature DB >> 28355091

Cytomegalovirus Retinitis: A Review.

Alexander D Port1, Anton Orlin1, Szilard Kiss1, Sarju Patel1, Donald J D'Amico1, Mrinali P Gupta1.   

Abstract

Cytomegalovirus (CMV) is a ubiquitous DNA herpes virus that causes significant morbidity and mortality in immunocompromised individuals. CMV retinitis is a potentially blinding manifestation of CMV infection that was commonly seen in advanced acquired immunodeficiency syndrome (AIDS) in the era before modern combination antiretroviral therapy era, but is also recognized in patients with immune deficiency from multiple causes. The advent of and advances in antiretroviral therapies for human immunodeficiency virus have decreased the incidence of CMV retinitis by over 90% among AIDS patients, and improved visual outcomes in those affected. The diagnosis is generally a clinical one, and treatment modalities include systemic and intravitreal antiviral medications. Retinal detachment and immune recovery uveitis are sight-threatening complications of CMV retinitis that require specific treatments.

Entities:  

Keywords:  cytomegalovirus; immune recovery uveitis; retinitis

Mesh:

Substances:

Year:  2017        PMID: 28355091     DOI: 10.1089/jop.2016.0140

Source DB:  PubMed          Journal:  J Ocul Pharmacol Ther        ISSN: 1080-7683            Impact factor:   2.671


  23 in total

1.  Retinal vascular inflammatory and occlusive changes in infectious and non-infectious uveitis.

Authors:  Toshikatsu Kaburaki; Hisako Fukunaga; Rie Tanaka; Hisae Nakahara; Hidetoshi Kawashima; Shintaro Shirahama; Hidetomo Izawa; Keiko Komae; Mitsuko Takamoto; Hirotsugu Soga; Makoto Aihara
Journal:  Jpn J Ophthalmol       Date:  2020-02-03       Impact factor: 2.447

2.  Cytomegalovirus retinitis following corticosteroid overdose for Vogt-Koyanagi-Harada disease.

Authors:  Sana Khochtali; Ahmed Mahjoub; Tarek Dridi; Imen Ksiaa; Nesrine Abroug; Moncef Khairallah
Journal:  Indian J Ophthalmol       Date:  2020-09       Impact factor: 1.848

3.  Clinical features of uveitis in elderly patients in central Tokyo (2013-2018).

Authors:  Shintaro Shirahama; Hirotsugu Soga; Rie Tanaka; Hisako Fukunaga; Hidetomo Izawa; Keiko Komae; Hisae Nakahara; Hidetoshi Kawashima; Makoto Aihara; Toshikatsu Kaburaki
Journal:  Int Ophthalmol       Date:  2021-02-05       Impact factor: 2.031

4.  Patterns of cytomegalovirus retinitis at a tertiary referral center in Turkey.

Authors:  Muhammed Talha Sadik; Nihan Aksu Ceylan; Zafer Cebeci; Nur Kir; Merih Oray; Ilknur Tugal-Tutkun
Journal:  Int Ophthalmol       Date:  2021-04-22       Impact factor: 2.031

5.  Cytomegalovirus retinitis in the post-cART era.

Authors:  Alexander D Port; Rolake O Alabi; Lisa Koenig; Mrinali P Gupta
Journal:  Curr Ophthalmol Rep       Date:  2018-05-02

6.  Ocular Outcomes after Treatment of Cytomegalovirus Retinitis Using Adoptive Immunotherapy with Cytomegalovirus-Specific Cytotoxic T Lymphocytes.

Authors:  Mrinali P Gupta; Lisa R Koenig; Ekaterina Doubrovina; Aisha Hasan; Parastoo B Dahi; Richard J O'Reilly; Guenther Koehne; Anton Orlin; Robison V Paul Chan; Donald J D'Amico; Susanna S Park; Bryn M Burkholder; Szilárd Kiss
Journal:  Ophthalmol Retina       Date:  2021-04-20

Review 7.  [Research progress on etiologic diagnosis of ocular viral diseases].

Authors:  Runping Duan; Yesheng Xu; Libin Zheng; Yufeng Yao
Journal:  Zhejiang Da Xue Xue Bao Yi Xue Ban       Date:  2020-10-25

8.  Presumed cytomegalovirus retinitis in a non-immune compromised patient with breast carcinoma during treatment: A case report.

Authors:  Chia-Chen Kao; Shiuh-Liang Hsu; Shwu-Jiuan Sheu
Journal:  Am J Ophthalmol Case Rep       Date:  2021-07-07

Review 9.  Practical Guidance for Clinical Microbiology Laboratories: Diagnosis of Ocular Infections.

Authors:  Sixto M Leal; Kyle G Rodino; W Craig Fowler; Peter H Gilligan
Journal:  Clin Microbiol Rev       Date:  2021-06-02       Impact factor: 50.129

10.  COVID-19: more than a respiratory virus, an optical coherence tomography study.

Authors:  Esra Dag Seker; Inci Elif Erbahceci Timur
Journal:  Int Ophthalmol       Date:  2021-07-27       Impact factor: 2.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.